Brentjens RJ, Davila ML, Riviere I, Park J, Wang X, Cowell LG et al (2013) CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med 5:177ra38
Article
PubMed
PubMed Central
Google Scholar
Davila ML, Riviere I, Wang X, Bartido S, Park J, Curran K et al (2014) Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med 6:224ra25
Article
PubMed
PubMed Central
Google Scholar
Kochenderfer JN, Dudley ME, Kassim SH, Somerville RP, Carpenter RO, Stetler-Stevenson M et al (2015) Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J Clin Oncol 33:540–549
CAS
Article
PubMed
Google Scholar
Lee DW, Kochenderfer JN, Stetler-Stevenson M, Cui YK, Delbrook C, Feldman SA et al (2015) T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial. Lancet 385:517–528
CAS
Article
PubMed
Google Scholar
Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ et al (2014) Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med 371:1507–1517
CAS
Article
PubMed
PubMed Central
Google Scholar
Porter DL, Hwang WT, Frey NV, Lacey SF, Shaw PA, Loren AW et al (2015) Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci Transl Med 7:303ra139
Article
PubMed
Google Scholar
Ramos CA, Heslop HE, Brenner MK (2016) CAR-T Cell Therapy for Lymphoma. Annu Rev Med 67:165–183
CAS
Article
PubMed
Google Scholar
Rosenberg SA, Restifo NP (2015) Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348:62–68
CAS
Article
PubMed
Google Scholar
Feldman SA, Assadipour Y, Kriley I, Goff SL, Rosenberg SA (2015) Adoptive cell therapy–tumor-infiltrating lymphocytes, T-cell receptors, and chimeric antigen receptors. Semin Oncol 42:626–639
Article
PubMed
Google Scholar
Curran KJ, Brentjens RJ (2015) Chimeric antigen receptor T cells for cancer immunotherapy. J Clin Oncol 33:1703–1706
CAS
Article
PubMed
Google Scholar
Kershaw MH, Westwood JA, Parker LL, Wang G, Eshhar Z, Mavroukakis SA et al (2006) A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer. Clin Cancer Res 12:6106–6115
CAS
Article
PubMed
PubMed Central
Google Scholar
Lamers CH, Sleijfer S, Vulto AG, Kruit WH, Kliffen M, Debets R et al (2006) Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience. J Clin Oncol 24:e20–e22
Article
PubMed
Google Scholar
Lamers CH, Willemsen R, van Elzakker P, van Steenbergen-Langeveld S, Broertjes M, Oosterwijk-Wakka J et al (2011) Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells. Blood 117:72–82
CAS
Article
PubMed
Google Scholar
Pule MA, Savoldo B, Myers GD, Rossig C, Russell HV, Dotti G et al (2008) Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nat Med 14:1264–1270
CAS
Article
PubMed
PubMed Central
Google Scholar
Berinstein NL (2002) Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: a review. J Clin Oncol 20:2197–2207
CAS
Article
PubMed
Google Scholar
Begent RH, Verhaar MJ, Chester KA, Casey JL, Green AJ, Napier MP et al (1996) Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library. Nat Med 2:979–984
CAS
Article
PubMed
Google Scholar
Chester KA, Bhatia J, Boxer G, Cooke SP, Flynn AA, Huhalov A et al (2000) Clinical applications of phage-derived sFvs and sFv fusion proteins. Dis Mark 16:53–62
CAS
Article
Google Scholar
Mayer A, Francis RJ, Sharma SK, Tolner B, Springer CJ, Martin J et al (2006) A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. Clin Cancer Res 12:6509–6516
CAS
Article
PubMed
Google Scholar
Gilham DE, O’Neil A, Hughes C, Guest RD, Kirillova N, Lehane M et al (2002) Primary polyclonal human T lymphocytes targeted to carcino-embryonic antigens and neural cell adhesion molecule tumor antigens by CD3zeta-based chimeric immune receptors. J Immunother 25:139–151
CAS
Article
PubMed
Google Scholar
Guest RD, Hawkins RE, Kirillova N, Cheadle EJ, Arnold J, O’Neill A et al (2005) The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens. J Immunother 28:203–211
CAS
Article
PubMed
Google Scholar
Hombach AA, Schildgen V, Heuser C, Finnern R, Gilham DE, Abken H (2007) T cell activation by antibody-like immunoreceptors: the position of the binding epitope within the target molecule determines the efficiency of activation of redirected T cells. J Immunol 178:4650–4657
CAS
Article
PubMed
Google Scholar
Sheen AJ, Irlam J, Kirillova N, Guest RD, Sherlock DJ, Hawkins RE et al (2003) Gene therapy of patient-derived T lymphocytes to target and eradicate colorectal hepatic metastases. Dis Colon Rectum 46:793–804
Article
PubMed
Google Scholar
Sheen AJ, Sherlock DJ, Irlam J, Hawkins RE, Gilham DE (2003) T lymphocytes isolated from patients with advanced colorectal cancer are suitable for gene immunotherapy approaches. Br J Cancer 88:1119–1127
CAS
Article
PubMed
PubMed Central
Google Scholar
Haynes NM, Snook MB, Trapani JA, Cerruti L, Jane SM, Smyth MJ et al (2001) Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma. J Immunol 166:182–187
CAS
Article
PubMed
Google Scholar
Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U et al (2008) Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol 26:5233–5239
CAS
Article
PubMed
PubMed Central
Google Scholar
Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415–419
CAS
Article
PubMed
Google Scholar
Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD et al (2006) Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355:1018–1028
CAS
Article
PubMed
Google Scholar
Guest RD, Kirillova N, Mowbray S, Gornall H, Rothwell DG, Cheadle EJ et al (2014) Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trial. Cancer Immunol Immunother 63:133–145
CAS
Article
PubMed
Google Scholar
Shi ZR, Tacha D, Itzkowitz SH (1994) Monoclonal antibody COL-1 reacts with restricted epitopes on carcinoembryonic antigen: an immunohistochemical study. J Histochem Cytochem 42:1215–1219
CAS
Article
PubMed
Google Scholar
Somerville RP, Devillier L, Parkhurst MR, Rosenberg SA, Dudley ME (2012) Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE(R) bioreactor. J Transl Med 10:69
Article
PubMed
PubMed Central
Google Scholar
Bridgeman JS, Hawkins RE, Hombach AA, Abken H, Gilham DE (2010) Building better chimeric antigen receptors for adoptive T cell therapy. Curr Gene Ther 10:77–90
CAS
Article
PubMed
Google Scholar
Klebanoff CA, Rosenberg SA, Restifo NP (2016) Prospects for gene-engineered T cell immunotherapy for solid cancers. Nat Med 22:26–36
CAS
Article
PubMed
Google Scholar
Katz SC, Burga RA, McCormack E, Wang LJ, Mooring W, Point GR et al (2015) Phase I hepatic immunotherapy for metastases study of intra-arterial chimeric antigen receptor-modified T-cell therapy for CEA + liver metastases. Clin Cancer Res 21:3149–3159
CAS
Article
PubMed
PubMed Central
Google Scholar
Pegram HJ, Park JH, Brentjens RJ (2014) CD28z CARs and armored CARs. Cancer J 20:127–133
CAS
Article
PubMed
PubMed Central
Google Scholar
Ahnen DJ, Nakane PK, Brown WR (1982) Ultrastructural localization of carcinoembryonic antigen in normal intestine and colon cancer: abnormal distribution of CEA on the surfaces of colon cancer cells. Cancer 49:2077–2090
CAS
Article
PubMed
Google Scholar
Boehm MK, Corper AL, Wan T, Sohi MK, Sutton BJ, Thornton JD et al (2000) Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts. Biochem J 346(Pt 2):519–528
CAS
Article
PubMed
PubMed Central
Google Scholar
Kim J, Kaye FJ, Henslee JG, Shively JE, Park JG, Lai SL et al (1992) Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers. Int J Cancer 52:718–725
CAS
Article
PubMed
Google Scholar
Klaile E, Klassert TE, Scheffrahn I, Muller MM, Heinrich A, Heyl KA et al (2013) Carcinoembryonic antigen (CEA)-related cell adhesion molecules are co-expressed in the human lung and their expression can be modulated in bronchial epithelial cells by non-typable Haemophilus influenzae, Moraxella catarrhalis, TLR3, and type I and II interferons. Respir Res 14:85
Article
PubMed
PubMed Central
Google Scholar
Morgan RA, Yang JC, Kitano M, Dudley ME, Laurencot CM, Rosenberg SA (2010) Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol Ther 18:843–851
CAS
Article
PubMed
PubMed Central
Google Scholar
Parkhurst MR, Yang JC, Langan RC, Dudley ME, Nathan DA, Feldman SA et al (2011) T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther 19:620–626
CAS
Article
PubMed
Google Scholar
Johnson L, June C (2017) Driving gene-engineered T cell immunnotherapy of cancer. Cell Res 27:38–58
CAS
Article
PubMed
Google Scholar